Download this datacard
Overview
Lobbying Costs
25,000€ - 49,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
0.2 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Mithra Pharmaceuticals
EU Transparency Register
997719149208-52 First registered on 23 Feb 2023
Goals / Remit
Mithra is a Belgian biotech company created in 1999 dedicated to transforming Women’s Health by offering new choices through innovation based on a unique molecule called Estetrol (E4), a native estrogen that offers a differentiated benefit/risk profile compared to existing hormone-based solutions. Thanks to the commitment of its employees based on two sites, among which a majority of women, Mithra stands by its goals to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra relies on two complementary innovative platforms: an Estetrol-based portfolio and Complex Therapeutics which are complemented by a unique manufacturing facility, Mithra CDMO and leveraged by Mithra’s know-how in long-acting drug development using polymer technology.
Main EU files targeted
General EU Pharmaceutical Legislation
Zero Pollution Action Plan
Women's HealthAddress
Head Office
Rue Saint-Georges 5
Liège 4000
BELGIUMEU Office
Rue Saint-Georges 5
Liège 4000
BELGIUMWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 10% 2 Lobbyists (Full time equivalent)
0.2
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Biowin
Essenscia
Eucope
Flandersbio
Pharma.be
FEAM
A3PMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
25,000€ - 49,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount d&d consulting services srl 25,000€ - 49,999€ Intermediaries for current year
Name d&d consulting services srl Closed year Costs
25,000€ - 49,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Conference: "Pharmaceuticals in the Environment: Current Challenges and Tomorrow’s Solutions to Protect Wildlife"
Other activities
None declared
Meetings
Meetings
None declared